11
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      COVID-19 can present with a rash and be mistaken for dengue

      letter

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          To the Editor: We found the report “What are we doing in the dermatology outpatient department amidst the raging of 2019-CoV?” to be very interesting. 1 Chen et al pointed out the need for a dermatology department to recognize and deal with this infection. We would like to share our experience from Thailand, the second country in which the COVID-19 infection occurred since early January 2020. 2 At present (March 5, 2020), there are 48 accumulated COVID-19 cases in Thailand. Among these 48 cases, there was an interesting case in which the patient presented with a skin rash with petechiae. Because dengue is very common in our setting, petechiae rash is a common clinical finding in dengue, and the patient also had low platelet count, a clinical diagnosis of dengue was made by the first physician in charge. There was no photograph and a biopsy was not done because biopsy is not a routine practice according to dengue clinical practice guidelines in our tropical setting. The patient was initially misdiagnosed as dengue, which resulted in a delayed diagnosis. 3 In this case, the patient further presented respiratory problems and was referred to the tertiary medical center. Other common virus infections that might cause fever, rash, and respiratory problem were ruled out by laboratory investigation, and the final diagnosis of COVID-19 infection was confirmed by RT-PCR. There is a possibility that a patient with COVID-19 might initially present with a skin rash that can be misdiagnosed as another common disease. In addition, some of these patients are afebrile initially. 4 The practitioner should recognize the possibility that the patient might have only a skin rash and think of this disease to prevent transmission.

          Related collections

          Most cited references4

          • Record: found
          • Abstract: found
          • Article: not found

          Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

          Summary Background A recent cluster of pneumonia cases in Wuhan, China, was caused by a novel betacoronavirus, the 2019 novel coronavirus (2019-nCoV). We report the epidemiological, clinical, laboratory, and radiological characteristics and treatment and clinical outcomes of these patients. Methods All patients with suspected 2019-nCoV were admitted to a designated hospital in Wuhan. We prospectively collected and analysed data on patients with laboratory-confirmed 2019-nCoV infection by real-time RT-PCR and next-generation sequencing. Data were obtained with standardised data collection forms shared by WHO and the International Severe Acute Respiratory and Emerging Infection Consortium from electronic medical records. Researchers also directly communicated with patients or their families to ascertain epidemiological and symptom data. Outcomes were also compared between patients who had been admitted to the intensive care unit (ICU) and those who had not. Findings By Jan 2, 2020, 41 admitted hospital patients had been identified as having laboratory-confirmed 2019-nCoV infection. Most of the infected patients were men (30 [73%] of 41); less than half had underlying diseases (13 [32%]), including diabetes (eight [20%]), hypertension (six [15%]), and cardiovascular disease (six [15%]). Median age was 49·0 years (IQR 41·0–58·0). 27 (66%) of 41 patients had been exposed to Huanan seafood market. One family cluster was found. Common symptoms at onset of illness were fever (40 [98%] of 41 patients), cough (31 [76%]), and myalgia or fatigue (18 [44%]); less common symptoms were sputum production (11 [28%] of 39), headache (three [8%] of 38), haemoptysis (two [5%] of 39), and diarrhoea (one [3%] of 38). Dyspnoea developed in 22 (55%) of 40 patients (median time from illness onset to dyspnoea 8·0 days [IQR 5·0–13·0]). 26 (63%) of 41 patients had lymphopenia. All 41 patients had pneumonia with abnormal findings on chest CT. Complications included acute respiratory distress syndrome (12 [29%]), RNAaemia (six [15%]), acute cardiac injury (five [12%]) and secondary infection (four [10%]). 13 (32%) patients were admitted to an ICU and six (15%) died. Compared with non-ICU patients, ICU patients had higher plasma levels of IL2, IL7, IL10, GSCF, IP10, MCP1, MIP1A, and TNFα. Interpretation The 2019-nCoV infection caused clusters of severe respiratory illness similar to severe acute respiratory syndrome coronavirus and was associated with ICU admission and high mortality. Major gaps in our knowledge of the origin, epidemiology, duration of human transmission, and clinical spectrum of disease need fulfilment by future studies. Funding Ministry of Science and Technology, Chinese Academy of Medical Sciences, National Natural Science Foundation of China, and Beijing Municipal Science and Technology Commission.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            What are we doing in the dermatology outpatient department amidst the raging of the 2019 novel coronavirus?

            In late December 2019, several individuals with unexplained pneumonia were reported in Wuhan, China. A novel coronavirus was subsequently identified as the causative pathogen and provisionally designated 2019 novel coronavirus (2019-nCoV). 1 As of February 10, 2020, 42,638 cases of 2019-nCoV infection have been confirmed in China, with 21,675 suspected cases and 1016 deaths. There are still more than 3000 confirmed cases every day, involving people living in or visiting Wuhan, as a subsequent characteristic of human-to-human transmission. 2019-nCoV continues to spread around the world and has been reported in other countries such as the United States. 2 Hospitals in all provinces and cities across China have taken effective measures to control the spread of 2019-nCoV. On January 24, 2020, the West China Hospital of Sichuan University temporarily shut the doors of its dermatology outpatient department and dermatology surgery by postponing all of the elective operations and limiting to only emergency operations. We did not, however, completely halt the services to some patients who need to visit the dermatology outpatient department during the 2019-nCoV outbreak. At the same time, to meet the medical requirements and reduce the flow of patients to the skin clinic, we began free online and telephone consultation by providing free dermatology consultations. The dermatology outpatient department in West China Hospital was scheduled to run on January 28, 2020, mainly for critical care patients. Patients who had made an advanced appointment for obtaining medical service but chose not to visit received a full refund of registration fees. The number of dermatology outpatient clinics has been drastically reduced from 8 to 4, and only 1 accompanying person is allowed to enter the clinic. People entering the outpatient and inpatient buildings must wear masks and have their body temperature monitored by professionals wearing tight protective clothing. At the entrance of the building, anyone with a fever (body temperature ≥37.3°C), travel history to Wuhan in last 2 weeks, clear contact with residents in Wuhan in last 2 weeks, or contact with people with a fever would be directly sent to the fever clinic for screening. These individuals are considered to have been exposed and are quarantined for 2 weeks, and potential exposures are also asked to quarantine themselves for 2 weeks at home. During the skin clinic, patients are not allowed to take off their masks except on indications of facial lesions. Doctors must wear masks, surgical caps, protective suits, gloves, and goggles at work; they take off their protective equipment only after their work in a designated disposable area. In other respects, educational programs and activities of West China Hospital have come to a halt; graduate students and interns are prohibited from returning to school and work. Also, West China Hospital established special psychologic intervention counseling via a telephone and network platform to help those in need and published a psychologic protection handbook for free download. It is uncertain to predict when the 2019-nCoV will end at the time of this writing. The West China hospital is still playing a powerful role in defending against the epidemic outbreak and is a microcosm of all of the countless Chinese hospitals at this moment.
              Bookmark
              • Record: found
              • Abstract: not found
              • Article: not found

              Editorial: Wuhan coronavirus outbreak and imported case

                Bookmark

                Author and article information

                Contributors
                Journal
                J Am Acad Dermatol
                J. Am. Acad. Dermatol
                Journal of the American Academy of Dermatology
                by the American Academy of Dermatology, Inc.
                0190-9622
                1097-6787
                22 March 2020
                May 2020
                22 March 2020
                : 82
                : 5
                : e177
                Affiliations
                [a ]Sanitation 1 Medical Academic Center, Bangkok, Thailand
                [b ]Department of Tropical Medicine, Hainan Medical University, Haikou, China
                [c ]Department of Tropical Medicine, Hainan Medical University, Haikou, China
                Author notes
                []Correspondence to: Beuy Joob, Sanitation 1 Medical Academic Center, Bangkok 10330, Thailand beuyjoob@ 123456hotmail.com
                Article
                S0190-9622(20)30454-0
                10.1016/j.jaad.2020.03.036
                7156802
                32213305
                98e8357d-b8d6-4814-9417-eed4712d385f
                © 2020 by the American Academy of Dermatology, Inc.

                Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.

                History
                Categories
                Article

                Comments

                Comment on this article